Patent details

EP3072963 Title: TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

Basic Information

Publication number:
EP3072963
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161675731
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
French Title of Invention:
TRANSLOCATION ET KINASE ROS MUTANTE DANS L'ÉPITHÉLIOMA PULMONAIRE HUMAIN À GRANDES CELLULES
German Title of Invention:
TRANSLOKATION UND MUTATIONS-ROS-KINASE BEI MENSCHLICHEM NICHT-KLEINZELLIGEM BRONCHIALKARZINOM
SPC Number:

Dates

Filing date:
20/10/2008
Grant date:
01/04/2020
EP Publication Date:
28/09/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/04/2020
EP B1 Publication Date:
01/04/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/10/2020
Expiration date:
20/10/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/03/2020
 
 

Name:
Cell Signaling Technology, Inc.
Address:
3 Trask Lane, Danvers, MA 01923, United States (US)

Inventor

1

Name:
GUO, Ailan
Address:
United States (US)

2

Name:
GU, Ting-lei
Address:
United States (US)

Priority

Priority Number:
999668 P
Priority Date:
18/10/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/16; C07K 14/00; C12N 15/00; C12P 21/02;

Publication

European Patent Bulletin

Issue number:
202014
Publication date:
01/04/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages